Previous close | 4.0600 |
Open | 4.0200 |
Bid | 4.1200 x 400 |
Ask | 4.1800 x 200 |
Day's range | 3.9800 - 4.1900 |
52-week range | 3.2400 - 11.0500 |
Volume | |
Avg. volume | 236,574 |
Market cap | 149.265M |
Beta (5Y monthly) | 0.07 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Key Insights scPharmaceuticals' Annual General Meeting to take place on 11th of June Total pay for CEO John Tucker...
Q1 2024 scPharmaceuticals Inc Earnings Call
Despite a net loss and increased operational costs, scPharmaceuticals Inc (SCPH) reports significant progress in product development and market expansion.